564
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Continuous extracorporeal clearance in metformin-associated lactic acidosis and metformin-induced lactic acidosis: a systematic review

ORCID Icon &
Pages 1266-1276 | Received 10 Dec 2021, Accepted 12 Sep 2022, Published online: 14 Oct 2022

References

  • Bailey CJ. Metformin revisited: its actions and indications for use. Diabet Med. 1988;5(4):315–320.
  • Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542–546.
  • Ekström N, Schiöler L, Svensson AM, et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2(4):e001076.
  • Kwon S, Kim YC, Park JY, et al. The long-term effects of metformin on patients with type 2 diabetic kidney disease. Diabetes Care. 2020;43(5):948–955.
  • Visconti L, Cernaro V, Ferrara D, et al. Metformin-related lactic acidosis: is it a myth or an underestimated reality? Ren Fail. 2016;38(9):1560–1565.
  • Calello DP, Liu KD, Wiegand TJ, et al. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med. 2015;43(8):1716–1730.
  • Donnino M, Montissol S, Andersen LW, et al. Metformin inhibits pyruvate dehydrogenase at high dosages: a potential mechanism for lactic acidosis. Acad Emerg Med. 2014;21:S181.
  • Fontaine E. Metformin-induced mitochondrial complex I inhibition: facts, uncertainties, and consequences. Front Endocrinol (Lausanne). 2018;9(753):753.
  • Blumenberg A, Benabbas R, Sinert R, et al. Do patients die with or from metformin-associated lactic acidosis (MALA)? Systematic review and meta-analysis of pH and lactate as predictors of mortality in MALA. J Med Toxicol. 2020;16(2):222–229.
  • Sirtori CR, Franceschini G, Galli-Kienle M, et al. Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther. 1978;24(6):683–693.
  • Tucker GT, Casey C, Phillips PJ, et al. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol. 1981;12(2):235–246.
  • Pentikäinen PJ, Neuvonen PJ, Penttilä A. Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol. 1979;16(3):195–202.
  • Lalau JD, Lacroix C. Measurement of metformin concentration in erythrocytes: clinical implications. Diabetes Obes Metab. 2003;5(2):93–98.
  • Fathima N, Kashif T, Janapala RN, et al. Single-best choice between intermittent versus continuous renal replacement therapy: a review. Cureus. 2019;11(9):e5558.
  • Schytz PA, Mace ML, Soja AM, et al. Impact of extracorporeal blood flow rate on blood pressure, pulse rate and cardiac output during haemodialysis. Nephrol Dial Transplant. 2015;30(12):2075–2079.
  • Douvris A, Zeid K, Hiremath S, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333–1346.
  • Acquistapace G, Rossi M, Garbi M, et al. Acute metformin intoxication: 2012 experience of Emergency Department of Lodi, Italy. Clin Chem Lab Med. 2014;52(10):1489–1497.
  • Aldobeaban S, Mzahim B, Alshehri AA. Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case report. J Med Case Rep. 2018;12(1):223.
  • Alivanis P, Giannikouris I, Paliuras C, et al. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006;28(3):396–400.
  • Aperis G, Paliouras C, Zervos A, et al. Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection. J Ren Care. 2011;37(1):25–29.
  • Arali A, Said TM, Hakim KA. Metabolic acidosis and rhabdomyolysis with metformin overdosage. BMB. 2015;37(4):256–259.
  • Arroyo AM, Walroth TA, Mowry JB, et al. The MALAdy of metformin poisoning: is CVVH the cure? Am J Ther. 2010;17(1):96–100.
  • Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol. 2002;40(2):177–180.
  • Bouchard NC, Weisstuch JM, Hoffman RS, et al. Metformin clearance is poor with continuous veno-venous hemodiafiltration. Clin Toxicol (Phila). 2004;42:739–740.
  • Cersosimo K, Iafisco A, Guastini R, et al. AKI and lactic acidosis: Metformin associated lactic acidosis (MALA) or sepsis? A case treated with continuous renal replacement therapy (CRRT). Blood Purif. 2021;50(3):432.
  • Chang CT, Chen YC, Fang JT, et al. High anion gap metabolic acidosis in suicide: Don’t forget metformin intoxication - two patients’ experiences. Ren Fail. 2002;24(5):671–675.
  • Chang CT, Chen YC, Fang JT, et al. Metformin-associated lactic acidosis: case reports and literature review. J Nephrol. 2002;15(4):398–402.
  • Chen T, Zhu C, Liu B. Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: a case report. Medicine (Baltimore). 2020;99(26):e20990.
  • Correia MS, Horowitz BZ. A critical appraisal of CRRT efficacy in metformin associated lactic acidosis. J Med Toxicol. 2021;17:111.
  • Cosenza L, Al-Dahir S, Engel LS, et al. A potentially fatal case of mistaken identity: Metformin vs oxycodone-acetaminophen. J Investig Med. 2011;59(2):385.
  • Cruz MD, Ershad M, Mostafa A. Metabolic acidosis and hyperlactatemia requiring continuous venovenous hemofiltration after intentional ingestion of Metformin. Indian J Nephrol. 2021;31(1):77–78.
  • Deepak V, Reaume M, Farishta M, et al. Metformin-associated lactic acidosis successfully treated with continuous renal replacement therapy. Crit Care Med. 2019;47(1):443.
  • El-Khoury B, Stewart IJ. Lactate rising: the “unconventional” use of continuous renal replacement therapy in metformin-associated lactic acidosis. J Am Soc Nephrol. 2019;30:1039.
  • Elmassry M, Mantilla B, Mortagy M, et al. An extremely low pH survivor: a case of septic shock complicated with metformin-induced severe lactic acidosis. J Investig Med. 2020;68(2):602.
  • Fadden EJ, Longley C, Mahambrey T. Metformin-associated lactic acidosis. BMJ Case Rep. 2021;14(7):e239154.
  • Ferguson C. Diarrhoea and vomiting leading to metformin associated lactic acidosis: a case report. Am J Respir Crit Care Med. 2018;197:A3372.
  • Fremin K, Owen J. Metformin overdose and early renal replacement therap. Am J Kid Dis. 2014;63(5):A47.
  • Friesecke S, Abel P, Kraft M, et al. Combined renal replacement therapy for severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2006;21(7):2038–2039.
  • Galea M, Jelacin N, Bramham K, et al. Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose. Br J Anaesth. 2007;98(2):213–215.
  • Galiero F, Consani G, Biancofiore G, et al. Metformin intoxication: vasopressin’s key role in the management of severe lactic acidosis. Am J Emerg Med. 2018;36(2):341.e5–341.e6.
  • Garg A, Sánchez-Solano NJ, Gorla SR, et al. Acute myocardial injury in association with metformin toxicity. J Pediatr Intensive Care. 2018;7(3):169–172.
  • Garg SK, Singh O, Deepak D, et al. Extracorporeal treatment with high-volume continuous venovenous hemodiafiltration and charcoal-based sorbent hemoperfusion for severe metformin-associated lactic acidosis. Indian J Crit Care Med. 2016;20(5):295–298.
  • Giuliani E, Albertini G, Vaccari C, et al. pH 6.68-surviving severe metformin intoxication. QJM. 2010;103(11):887–890.
  • Gómez-Navarro L, de Arriba G, Sánchez-Heras M, et al. The nephrologist’s role in metformin-induced lactic acidosis. Nefrologia. 2011;31(5):587–590.
  • Griffin BR, Ambruso S, Jovanovich A, et al. Continuous renal replacement therapy dosing in the severely underweight: a case report. Kidney Med. 2019;1(4):217–220.
  • Guo Y, Dotherow P, Wiley T, et al. A case of intravenous angiotensin II in the treatment of vasodilatory shock due to drug overdose. Crit Care Med. 2019;47(1):832.
  • Halderman AK, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. J Am Soc Nephrol. 2021;32:139.
  • Harvey B, Hickman C, Hinson G, et al. Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. Pediatr Crit Care Med. 2005;6(5):598–601.
  • Hermez K, Dudash-Mion C. Profound metabolic acidosis due to metformin intoxication requiring dialysis. Case Rep Nephrol. 2021;2021:9914982.
  • Hooda A, Mehta A, Hannallah F. Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy. BMJ Case Rep. 2018;11(1):e227102.
  • Huberlant V, Laterre PF, Hantson P. Nearly fatal metabolic acidosis: Septic or toxic? Eur J Emerg Med. 2010;17(4):243–244.
  • Jagia M, Taqi S, Hanafi M. Metformin poisoning: a complex presentation. Indian J Anaesth. 2011;55(2):190–192.
  • Juneja P, Kazim K, Baldino M, et al. Metformin-associated lactic acidosis with profound hypothermia in a dialysis patient. Chest. 2020;158(4):A927.
  • Kinoshita H, Yanai M, Ariyoshi K, et al. A patient with metformin-associated lactic acidosis successfully treated with continuous renal replacement therapy: a case report. J Med Case Rep. 2019;13(1):371.
  • Lai K. The metformin gap. Chest. 2020;158(4):A748.
  • Leung S, Kent R, Sivaraman S, et al. Rapid restoration of hemodynamic stability in patients with metformin-associated lactic acidosis after renal replacement therapy. Crit Care Med. 2009;37(12):A521.
  • Liu S, Xu L, Ma J, et al. High-volume continuous venovenous hemodiafiltration plus resin hemoperfusion improves severe metformin-associated toxicity. J Diabetes Investig. 2018;9(4):975–978.
  • Livshits Z, Nelson L, Hernandez S, et al. Severe metformin toxicity: Role of methylene blue and CVVHD as therapeutic adjuncts. Clin Toxicol (Phila). 2010;48(6):611–612.
  • Mujtaba M, Geara AS, Madhrira M, et al. Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy. Eur J Drug Metab Pharmacokinet. 2012;37(4):249–253.
  • Mustafa E, Lai L, Lien YH. Rapid recovery from acute kidney injury in a patient with metformin-associated lactic acidosis and hypothermia. Am J Med. 2012;125(2):e1–e2.
  • Nakamura A, Suzuki K, Imai H, et al. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. BMJ Case Rep. 2017;2017:bcr2016218318.
  • Ncomanzi D, Sicat RMR, Sundararajan K. Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report. J Med Case Rep. 2014;8:159.
  • Nishihama K, Maki K, Okano Y, et al. A case of type 2 diabetes mellitus with metformin-associated lactic acidosis initially presenting the appearance of a sulfonylurea-related hypoglycemic attack. Acute Med Surg. 2017;4(1):123–126.
  • Ozeki T, Kawato R, Watanabe M, et al. A fatal case of metformin-associated lactic acidosis. Intern Med. 2016;55(7):775–778.
  • Pan LTT, MacLaren G. Continuous venovenous haemodiafiltration for metformin-induced lactic acidosis. Anaesth Intensive Care. 2009;37(5):830–832.
  • Parmar K, Vutthikraivit W. Continuous renal replacement therapy in management of metformin-induced lactic acidosis. Chest. 2020;158(4):A992.
  • Pessoa A, Quintela J, Tavares S, et al. When a harmless procedure causes a life-threatening problem: a case report of metformin-associated lactic acidosis following a colonoscopy. Pract Diab. 2019;36(1):22–24.
  • Pikwer A, Vernersson E, Frid A, et al. Extreme lactic acidosis type B associated with metformin treatment. NDT Plus. 2011;4(6):399–401.
  • Raoof S. Metformin associated lactic acidosis. Am J Resp Crit Care Med. 2019;199(9).
  • Rhee G, Nguyen M, Rodricks M, et al. Multi-organ failure following metformin re-exposure in a patient with previous history of metformin-associated lactic acidosis: a case report. J Am Coll Clin Pharm. 2019;2(5):597.
  • Rizer J, King J, Holstege C. Severe metformin toxicity with highest recorded surviving level treated with aggressive extracorporeal therapy. Clin Toxicol (Phila). 2018;56(10):998–999.
  • Sardarli K, Leong R, Gill I, et al. A patient with combined metformin-induced lactic acidosis and euglycemic diabetic ketoacidosis. J Am Soc Nephrol. 2021;32:384.
  • Schopman JE, Bouman CS, Canté CM, et al. Use of two continuous venovenous haemofiltration devices in metformin-associated lactic acidosis. Neth J Crit Care. 2017;25(1):15–17.
  • Schwetz V, Eisner F, Schilcher G, et al. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis. Wien Klin Wochenschr. 2017;129(17–18):646–649.
  • Sendil S, Yarlagadda K, Lawal H, et al. Metformin associated lactic acidosis in the intensive care unit: a rare condition mimicking sepsis. Cureus. 2020;12(7):e9119.
  • Seo JH, Lee DY, Hong CW, et al. Severe lactic acidosis and acute pancreatitis associated with cimetidine in a patient with type 2 diabetes mellitus taking metformin. Intern Med. 2013;52(19):2245–2248.
  • Shaughnessy GF, Nelson DR. Cardiac arrest due to severe metformin-associated lactic acidosis. Am J Respir Crit Care Med. 2017;195:A3775.
  • Shirazy M, Hakim K, Chaari A, et al. Systemic vascular resistance guided vasopressor dose titration in a case of vasodilator shock caused by metformin. Bahrain Med Bull. 2019;41(4):260–262.
  • Silvestre J, Carvalho S, Mendes V, et al. Metformin-induced lactic acidosis: a case series. J Med Case Rep. 2007;1:126.
  • Tasnim S, Dave D, Dweik A, et al. Metformin associated lactic acidosis mimicking ischemic bowel disease. J Investig Med. 2021;69(2):662.
  • Thurston R, Ibrahim BB, Durr JA, et al. A puzzling case of metformin (MF) associated lactic acidosis (MALA). J Am Soc Nephrol. 2018;29:576.
  • Tuncali B, Temizkan Kırkayak T, Zeyneloğlu P. Continuous veno-venous hemodiafiltration in metformin-associated lactic acidosis caused by a suicide attempt: a report of two cases. Ulus Travma Acil Cerrahi Derg. 2021;27(5):595–599.
  • Van Laethem K, Dewulf B, Bourgeois M. Management of a metformin-associated lactic acidosis by different modalities of renal replacement therapy. Intensive Care Med Exp. 2020;8(2): 001553.
  • Wang TH, Tsai WJ, Li YT, et al. Severe metformin poisoning survived by continuous venovenous hemofiltration and extracorporeal membrane oxygenation. Clin Toxicol (Phila). 2013;51:366.
  • Watkins SA, Boesen KJ, Shirazi FM. CRRT for metformin toxicity: is it enough? Clin Toxicol (Phila). 2018;56(10):1002–1003.
  • Watson J, Mora A. An extreme case of metformin-associated lactic acidosis with a remarkable outcome. Chest. 2016;150(4):441A.
  • Wolk B, Cao K. Medications matter: a case of metformin-associated lactic acidosis. Am J Resp Crit Care Med. 2017;195:A3774.
  • Yang PW, Lin KH, Lo SH, et al. Successful treatment of severe lactic acidosis caused by a suicide attempt with metformin overdose. Kaohsiung J Med Sci. 2009;25(2):93–97.
  • Yeh M, Cavanaugh J, Eisenstat MD, et al. Severe lactic acidosis and hemodynamic instability in combined metformin and amlodipine overdose treated with continuous renal replacement therapy (CRRT). J Med Toxicol. 2021;17:111–112.
  • Yousaf H, Kemp C. Metformin and chronic kidney disease type b lactic acidosis. Crit Care Med. 2018;46(1):660–660.
  • Zoppellari R, Bortolazzi S, Petrini S, et al. A case of cardiac arrest related to therapeutic use of metformin: clinical and toxicological aspects. Clin Toxicol (Phila). 2013;51:365–366.
  • Bruijstens LA, van Luin M, Buscher-Jungerhans PM, et al. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J Med. 2008;66(5):185–190.
  • Dichtwald S, Weinbroum AA, Sorkine P, et al. Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy. Diabet Med. 2012;29(2):245–250.
  • Duong JK, Furlong TJ, Roberts DM, et al. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf. 2013;36(9):733–746.
  • Young T, Cevallos J, Napier J, et al. Metformin poisoning treated with high dose insulin dextrose therapy: a case series. Acta Med Litu. 2019;26(1):72–78.
  • Keller G, Cour M, Hernu R, et al. Management of metformin-associated lactic acidosis by continuous renal replacement therapy. PLoS One. 2011;6(8):e23200.
  • Uusalo P, Järvisalo MJ. Mortality and renal prognosis in isolated metformin-associated lactic acidosis treated with continuous renal replacement therapy and citrate-calcium-anticoagulation. Acta Anaesthesiol Scand. 2020;64(9):1305–1311.
  • Wen YK. Impact of acute kidney injury on metformin-associated lactic acidosis. Int Urol Nephrol. 2009;41(4):967–972.
  • Yeung CW, Chung HY, Fong BM, et al. Metformin-associated lactic acidosis in chinese patients with type II diabetes. Pharmacology. 2011;88(5-6):260–265.
  • Mariano F, Pozzato M, Inguaggiato P, et al. Metformin-associated lactic acidosis undergoing renal replacement therapy in intensive care units: a five-million population-based study in the North-West of Italy. Blood Purif. 2017;44(3):198–205.
  • Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila). 2014;52(2):129–135.
  • Dell’Aglio DM, Perino LJ, Kazzi Z, et al. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med. 2009;54(6):818–823.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.